Correction to “Renal cell carcinoma in the contralateral kidney with TFE3 gene translocation following chemotherapy for childhood nephroblastoma: A case report and literature review”

IF 0.6 Q3 MEDICINE, GENERAL & INTERNAL

Clinical Case Reports Pub Date : 2024-11-07 DOI:10.1002/ccr3.9410

引用次数: 0

Abstract

Fujisawa S, Furukawa J, Hara T, et al. Renal cell carcinoma in the contralateral kidney with TFE3 gene translocation following chemotherapy for childhood nephroblastoma: a case report and literature review. Clin Case Rep. 2023;11(11):e8128.

One of coauthors' name is currently listed as “Keiske Okada,” but the correct spelling is “Keisuke Okada.”

We apologize for this error.

查看原文本刊更多论文

更正 "儿童肾母细胞瘤化疗后患有 TFE3 基因易位的对侧肾脏肾细胞癌：病例报告和文献综述"。

[此处更正了文章 DOI：10.1002/ccr3.8128.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Case Reports MEDICINE, GENERAL & INTERNAL-

自引率

14.30%

发文量

1268

审稿时长

13 weeks

期刊介绍： Clinical Case Reports is different from other case report journals. Our aim is to directly improve global health and increase clinical understanding using case reports to convey important best practice information. We welcome case reports from all areas of Medicine, Nursing, Dentistry, and Veterinary Science and may include: -Any clinical case or procedure which illustrates an important best practice teaching message -Any clinical case or procedure which illustrates the appropriate use of an important clinical guideline or systematic review. As well as: -The management of novel or very uncommon diseases -A common disease presenting in an uncommon way -An uncommon disease masquerading as something more common -Cases which expand understanding of disease pathogenesis -Cases where the teaching point is based on an error -Cases which allow us to re-think established medical lore -Unreported adverse effects of interventions (drug, procedural, or other).